A next-generation nanobody-liposome treatment slashes tumor growth by homing in on a key cancer marker, opening new doors for safer and more effective lung cancer therapy.
Study: Targeting CD155 in lung adenocarcinoma: A5…
New nanobody-liposome combo stops lung cancer growth and delivers targeted chemotherapy
